Long-Term Care After Brain Injury: A Physician’s Assessment of Lifetime Needs

By Ellia Ciammaichella, DO, JD
Triple Board-Certified in Physical Medicine & Rehabilitation, Spinal Cord Injury Medicine, and Brain Injury Medicine

Why Brain Injury Is a Lifetime Condition, Not an Acute Episode

The single most common mistake I encounter in brain injury cases is the assumption that recovery tracks like a sprained ankle. It does not. Severe TBI behaves as a chronic disease process, and the evidence base has been clear on this for more than a decade. A 2024 systematic review in Eur J Phys Rehabil Med of 24 studies confirmed that severe TBI is associated with reduced life expectancy compared with the general population, with the magnitude of reduction varying by age at injury, injury severity, and the level of post-injury disability. That is not a prognosis you can capture in a three-month discharge summary.

The implication for long-term care planning is direct. A brain injury survivor at age 32 is not “returning to baseline.” They are entering a new baseline, and that baseline will interact with normal aging, with secondary conditions like post-traumatic epilepsy and endocrine dysfunction, and with the social determinants of their household. A physician who signs off on a lifetime needs assessment without acknowledging this trajectory is not doing the patient or the fact-finder any favors.

What a Physician’s Assessment Actually Includes

The American Academy of Physical Medicine and Rehabilitation puts it plainly: life care planning is a natural fit within physical medicine and rehabilitation, because physiatrists spend their careers assessing functional impairments and planning for future needs. A physician life care planner can independently formulate and defend medical opinions about future care. That independence is what distinguishes a medical opinion from a commercial cost projection.

When I build a lifetime needs assessment, I work through a defined set of domains. The aim is to produce a document where every line item is causally tied to the injury and where every cost is tied to a clinical recommendation I am prepared to defend.

Functional Outcomes and Return-to-Work Realities

Counsel often asks me a variation of a single question: what are the odds this person gets back to work? The honest answer is “it depends on the phenotype.” A 2018 cohort study in Ann Phys Rehabil Med followed 91 severe TBI survivors and reported a return-to-work rate of 63.7%. That headline number tells you almost nothing by itself. What makes the study useful is the predictor set. The investigators identified education level, motor disability, and behavioural disorder as the factors most associated with long-term return to work.

Translate that into plain language. A college-educated survivor with intact mobility and no significant behavioural disruption has one trajectory. A survivor with a high-school education, hemiparesis, and disinhibition has a different trajectory. Collapsing those two patients into a single “63.7%” figure is not evidence-based practice. It is the kind of shortcut that produces life care plans that either overshoot or undershoot the actual need.

When a defense report cites a population-level return-to-work figure without engaging the patient’s predictor profile, you should expect a physician on your side to flag that gap. Predictors matter more than headline percentages.

The Economics of Doing This Right

There is a persistent myth that specialist rehabilitation and long-horizon care planning are luxuries that inflate claim value. The peer-reviewed economics tell a different story.

The complementary piece of evidence comes from a 2013 multi-centre study in Brain Injury, which reported clinical and cost-benefits of up to £1.13M per patient for neurobehavioural rehabilitation admitted within the first year after injury, and up to £0.86M per patient for admissions beyond one year. The framing is not “early or nothing.” It is “early is best, but late is still materially better than nothing.” Long-term care for brain injury patients is cheaper when it is planned, not when it is rationed.

The legal implication is also simple. A life care plan that omits specialist rehabilitation line items on the theory that they are “optional” is ignoring the cost-effectiveness evidence. The cheapest path across a 30-year horizon is usually the one that funds structured rehabilitation at the right intensity at the right time.

Caregiver Burden and Why It Belongs in the Plan

Most life care plans I review underfund the caregiver. That is not an emotional observation. It is an economic one. The Model Systems Knowledge Translation Center, the NIDILRR-funded clearinghouse for TBI consumer resources at msktc.org/tbi, publishes a library of family and caregiver factsheets for exactly this reason. The caregiver is the single point of failure in nearly every long-term care plan I touch. When the caregiver burns out, the patient decompensates, admissions escalate, and the plan that looked affordable on paper becomes the most expensive version of itself.

A physician-built assessment addresses this directly. That means:

• Respite care as a line item, not as an aspiration. A defined number of hours per month, with a replacement cycle for the respite provider.
• Caregiver mental health support budgeted explicitly, because caregiver depression drives avoidable patient hospitalizations.
• Training and re-training for caregivers as the patient’s needs change across the lifespan.
• A documented transition plan for what happens when the primary caregiver, usually a parent or spouse, can no longer perform the role.

The last item is the one most often missing, and it is the one that matters most in the last decade of the plan horizon. In my practice, I will not sign off on a lifetime needs assessment that does not include a written transition plan for caregiver succession.

Building Continuity of Care Across Decades

Where the previous section addressed caregiver succession — the question of who fills the family-and-daily-support role over time — this section addresses a different failure point: continuity of the clinical team itself. A plan can have a durable caregiver and still fall apart if no physician owns the medical throughline.

Continuity is the quiet driver of long-term outcomes. A patient who has one physiatrist reviewing their case every six to twelve months, coordinating with neurology, psychiatry, and primary care, will usually outperform a patient of identical injury severity who is bounced from specialist to specialist without a care coordinator. This is not controversial within rehabilitation medicine, but it is chronically under-resourced.

In a defensible lifetime plan, continuity appears as two explicit line items. The first is a named medical home, typically physiatry-led, with a defined frequency of visits and a defined scope. The second is a care coordinator or case manager with budgeted hours sufficient to do the work, not a symbolic allocation. When I see a plan with “care coordination” listed at two hours per month across a 30-year horizon, I flag it. Two hours a month across a complex case is a clerical allocation. It is not care coordination.

Continuity also means anticipating transitions. A 25-year-old survivor will eventually become a 65-year-old survivor. The care team that worked at 25 will not be the care team that works at 65. A serious assessment names the transitions, prices them, and builds in the overlap time that makes them safe.

The Life-Expectancy Question

The question that makes every room quiet is the life-expectancy question. Defense counsel will ask it. Plaintiff counsel will ask it. Families usually cannot bring themselves to ask it out loud. An honest physician answer engages the evidence without pretending to certainty we do not have.

As the De Tanti systematic review cited earlier established, severe TBI is associated with reduced life expectancy, with the magnitude varying by age at injury, injury severity, and post-injury disability. The operative question in a life care plan is not whether life expectancy is reduced — the literature settles that — but by how much, for this patient, and how that specific reduction drives the cost tail. A well-rehabilitated 30-year-old with good functional recovery sits on a very different actuarial curve than a 60-year-old with severe disability and limited mobility, and the dollar difference between those two curves, compounded across a 30-year horizon, is often the single largest swing in the plan.

The life-expectancy input is also where opposing experts most often diverge. A defense expert will typically select a subgroup from the literature with the most aggressive reduction estimate and extrapolate from it. A plaintiff expert may default to general-population tables and ignore the TBI-specific literature entirely. Neither posture survives cross-examination. A defensible plan shows its work: it names the specific subgroup of the literature being applied (age band, severity classification, functional-outcome tier), explains why that subgroup fits the patient, and cites the underlying data. That level of specificity is what allows a life-expectancy opinion to hold up when a rival expert challenges the input.

For planning purposes, the practical rule is that life-expectancy assumptions must be patient-specific, literature-grounded, and transparent about the subgroup selection. Anything less is either evidence-free optimism or evidence-free pessimism, and neither belongs in a medical-legal document.

Conclusion: What This Means for the Medical-Legal File

A physician assessment of lifetime needs is not a sales document. It is a clinical record that must survive cross-examination. In my review work across nearly two decades, the assessments that hold up share a small number of features. They are built from a clinical examination, not a chart review alone. They cite peer-reviewed literature where a claim depends on literature. They distinguish first-person clinical observation from published data. They price line items to replacement cycles. They acknowledge uncertainty where it exists and do not manufacture certainty where it does not.

For plaintiff attorneys, the operational advice is to retain a physician who will write the assessment they will later have to defend, not the one they think you want. The evidence base is specific enough now that a well-constructed plan will beat a poorly-constructed one on the merits, regardless of which side commissions it.

Frequently Asked Questions